$56.99
0.58[1.03%]
Last update: 9:29AM Get Real Time Here
CRISPR Therapeutics
(NASDAQ:CRSP)CRISPR Therapeutics Stock (NASDAQ:CRSP), Earnings Estimates, EPS, and Revenue
CRISPR Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-1.420
Quarterly Revenue Estimate
$17.5M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$370M
Analyze the earnings history of CRISPR Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/06/2024 | PM | CRSP | Q1 | -$0.67 | -$1.42 | — | — | $100.00M | $17.51M | — | — | Get Alert |
| 02/21/2024 | AM | CRSP | Q4 | -$1.41 | -$0.07 | $1.10 | 1671.43% | $6.00K | $131.63M | $201.21M | 52.86% | Get Alert |
| 11/06/2023 | PM | CRSP | Q3 | -$2.24 | -$1.96 | -$1.41 | 28.06% | $94.00K | $8.43M | $0.00 | -100.00% | Get Alert |
| 08/07/2023 | PM | CRSP | Q2 | -$2.40 | -$2.12 | -$0.98 | 53.77% | $158.00K | $1.71M | $70.00M | 3993.57% | Get Alert |
| 05/08/2023 | PM | CRSP | Q1 | -$2.32 | -$1.70 | -$0.67 | 60.59% | $940.00K | $22.98M | $100.00M | 335.16% | Get Alert |
| 02/21/2023 | PM | CRSP | Q4 | -$1.84 | -$2.30 | -$1.41 | 38.70% | $12.90M | $7.12M | $6.00K | -99.92% | Get Alert |
| 11/01/2022 | PM | CRSP | Q3 | -$1.67 | -$2.29 | -$2.24 | 2.18% | $824.00K | $1.62M | $94.00K | -94.20% | Get Alert |
| 08/08/2022 | AM | CRSP | Q2 | $9.44 | -$2.23 | -$2.40 | -7.62% | $900.70M | $2.06M | $158.00K | -92.33% | Get Alert |
| 05/09/2022 | PM | CRSP | Q1 | -$1.51 | — | -$2.32 | — | $539.00K | — | $940.00K | — | Get Alert |
| 02/15/2022 | PM | CRSP | Q4 | -$1.50 | -$1.77 | -$1.84 | -3.95% | $370.00K | $2.27M | $12.90M | 468.24% | Get Alert |
| 11/03/2021 | PM | CRSP | Q3 | -$1.32 | -$1.76 | -$1.67 | 5.11% | $148.00K | $1.12M | $824.00K | -26.43% | Get Alert |
| 07/29/2021 | PM | CRSP | Q2 | -$1.30 | $3.52 | $9.44 | 168.18% | $44.00K | $420.92M | $900.70M | 113.98% | Get Alert |
| 04/27/2021 | PM | CRSP | Q1 | -$1.15 | -$1.47 | -$1.51 | -2.72% | $157.00K | $1.14M | $539.00K | — | Get Alert |
| 02/16/2021 | PM | CRSP | Q4 | $0.51 | -$1.27 | -$1.50 | -18.11% | $77.02M | $2.32M | $370.00K | -84.05% | Get Alert |
| 10/28/2020 | AM | CRSP | Q3 | $2.40 | -$1.18 | -$1.32 | -11.86% | $211.93M | $2.06M | $148.00K | -92.82% | Get Alert |
| 07/27/2020 | PM | CRSP | Q2 | -$1.01 | -$0.95 | -$1.30 | -36.84% | $318.00K | $18.12M | $44.00K | -99.76% | Get Alert |
| 04/28/2020 | PM | CRSP | Q1 | -$0.93 | — | -$1.15 | — | $328.00K | — | $157.00K | — | Get Alert |
| 02/12/2020 | PM | CRSP | Q4 | -$0.92 | — | $0.51 | — | $115.00K | — | $77.02M | — | Get Alert |
| 10/28/2019 | AM | CRSP | Q3 | -$1.07 | — | $2.40 | — | $563.00K | — | $211.93M | — | Get Alert |
FAQ
When is CRISPR Therapeutics (NASDAQ:CRSP) reporting earnings?
CRISPR Therapeutics (CRSP) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on February 21, 2024 for Q4.
What were the latest earnings per share (EPS) for CRISPR Therapeutics (NASDAQ:CRSP)?
The Actual EPS was $1.10, which beat the estimate of $-0.07.
What were CRISPR Therapeutics’s (NASDAQ:CRSP) revenues?
The Actual Revenue was $201.2M, which beat the estimate of $131.6M.
Browse earnings estimates, EPS, and revenue on all stocks.